raziel therapeutics raised €20M in a Series C round in Oct 2019. The company is based in Rehovot, Israel. Investors in the round: Pontifax. Data as of 6 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
